Clinical Social Workers in Stafford, TX Accepting Medicare

9 Clinical Social Workers found. Showing 1 - 9

Phyllicia Fisher, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1025 Dulles Ave Apt 1128, Stafford, TX 77477 Phone: 678-687-8172

Kristina Tutt, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12840 S Kirkwood Rd Apt 1021, Stafford, TX 77477 Phone: 832-205-6080

Mrs. Joanna A. Jones, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4434 Bluebonnet Dr, Suite #116, Stafford, TX 77477 Phone: 713-826-5032

Ms. Terri Kay Lively, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10707 Corporate Dr, Suite 150, Stafford, TX 77477 Phone: 281-494-9100    Fax: 281-494-9115

Sarah Mckeever, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12371 S Kirkwood Rd, Stafford, TX 77477 Phone: 713-995-9292

Terri Kidd, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12371 S Kirkwood Rd, Stafford, TX 77477 Phone: 713-995-9292    Fax: 713-779-0204

Kyoko Wyrick, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12371 S Kirkwood Rd, Stafford, TX 77477 Phone: 713-995-9292

Apolonia Williams Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 435 Murphy Rd # 233, Stafford, TX 77477 Phone: 832-475-4497

Mrs. Nyela Simone Bolden, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2827 Lelia St, Stafford, TX 77477 Phone: 832-228-5160

News Archive

TenX Biopharma recommences enrollment in suspended Phase III trial for cutaneous T-cell lymphoma

TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.

New European Society launched to accelerate Organ-on-Chip research

The new European Organ-on-Chip Society was officially launched at the third International Organ-on-Chip Symposium, held on 8 and 9 November 2018 at the University of Technology in Eindhoven, the Netherlands.

Study underscores why COVID-19 vaccine boosters are important for all adults

As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.

NIST's new reference can aid in Huntington's disease diagnosis

A new Standard Reference Material from the National Institute of Standards and Technology will help clinical genetics labs accurately diagnose Huntington's disease, an inherited degenerative brain disorder that usually begins between ages 35 and 50 and progressively leads to physical impairment, dementia and death.

Read more Medical News

› Verified 7 days ago